These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 26586047

  • 1. Is there a genetic predisposition to new-onset diabetes after kidney transplantation?
    Reddy YN, Abraham G, Sundaram V, Reddy PP, Mathew M, Nagarajan P, Mehra N, Ramachandran A, Ali AA, Reddy YN.
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1113-20. PubMed ID: 26586047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E, Delgado P, Alvarez A, Cobo M, Pérez L, González-Posada JM, Hortal L, Gallego R, García JJ, Checa M, Morales A, Salido E, Hernández D, Torres A.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [Abstract] [Full Text] [Related]

  • 4. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM, Taylor-Robinson AW, Wu YS, Gan SH, Zaharan NL, Basu RC, Liew CSL, Wan Md Adnan WAH.
    BMC Nephrol; 2020 Sep 07; 21(1):388. PubMed ID: 32894076
    [Abstract] [Full Text] [Related]

  • 5. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK, Bhowmik D, Mahajan S, Bagchi S.
    Transpl Infect Dis; 2017 Feb 07; 19(1):. PubMed ID: 27775825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysis.
    Nishimura K, Kishikawa H, Kato T, Kobayashi Y, Fujii N, Takahara S, Ichikawa Y.
    Transpl Int; 2009 Jul 07; 22(7):694-701. PubMed ID: 19254242
    [Abstract] [Full Text] [Related]

  • 8. New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?
    Santos AH, Chen C, Casey MJ, Womer KL, Wen X.
    Nephrol Dial Transplant; 2018 Jan 01; 33(1):177-184. PubMed ID: 29045704
    [Abstract] [Full Text] [Related]

  • 9. Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients.
    Gaynor JJ, Ciancio G, Guerra G, Sageshima J, Hanson L, Roth D, Goldstein MJ, Chen L, Kupin W, Mattiazzi A, Tueros L, Flores S, Barba LJ, Lopez A, Rivas J, Ruiz P, Vianna R, Burke GW.
    Clin Transplant; 2015 Apr 01; 29(4):301-10. PubMed ID: 25581205
    [Abstract] [Full Text] [Related]

  • 10. Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.
    Ramesh Prasad GV, Huang M, Bandukwala F, Nash MM, Rapi L, Montada-Atin T, Meliton G, Zaltzman JS.
    Clin Nephrol; 2009 Feb 01; 71(2):140-6. PubMed ID: 19203506
    [Abstract] [Full Text] [Related]

  • 11. New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression.
    Luan FL, Steffick DE, Ojo AO.
    Transplantation; 2011 Feb 15; 91(3):334-41. PubMed ID: 21242885
    [Abstract] [Full Text] [Related]

  • 12. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus.
    Elens L, Sombogaard F, Hesselink DA, van Schaik RH, van Gelder T.
    Pharmacogenet Genomics; 2013 Dec 15; 23(12):649-57. PubMed ID: 24113216
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Transpl Immunol; 2014 Aug 15; 31(2):87-91. PubMed ID: 24932812
    [Abstract] [Full Text] [Related]

  • 14. Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.
    Nagaraja P, Ravindran V, Morris-Stiff G, Baboolal K.
    Transpl Int; 2013 Mar 15; 26(3):273-80. PubMed ID: 23230898
    [Abstract] [Full Text] [Related]

  • 15. New-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.
    Sinangil A, Celik V, Barlas S, Sakaci T, Koc Y, Basturk T, Akin EB, Ecder T.
    Prog Transplant; 2016 Mar 15; 26(1):55-61. PubMed ID: 27136250
    [Abstract] [Full Text] [Related]

  • 16. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A, Moore RH, Baboolal K.
    Transplantation; 2006 Dec 27; 82(12):1667-72. PubMed ID: 17198257
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ, Li J, Zuo SR, Zhang YP, Jia SJ, Yuan H, Liu SK, Cheng K, Ming YZ, Zuo XC, Luo AJ, Xie WZ, Cai JJ, Yang M, Wang JL.
    Ren Fail; 2015 May 27; 37(4):601-6. PubMed ID: 25644968
    [Abstract] [Full Text] [Related]

  • 19. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria.
    Rodrigo E, Santos L, Piñera C, Quintanar JA, Ruiz JC, Fernández-Fresnedo G, Palomar R, Gómez-Alamillo C, Arias M.
    Transplant Proc; 2011 May 27; 43(6):2208-10. PubMed ID: 21839235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.